Naprosyn
- Product NDC
- 0121-0899
- 11-digit product format
- 001210899
- Labeler code
- 0121
- Product ID
- 0121-0899_b69c968c-613a-ad3a-e053-2995a90af9d2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naproxen
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Pharmaceutical Associates, Inc.
- Application
- NDA018965
- Marketing category
- NDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0121-0899-20 | 00121089920 | 2 TRAY in 1 CASE (0121-0899-20) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (0121-0899-05) | 2 tray | 2020-07-24 | 0000-00-00 | No | No | Current |